These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7358207)

  • 41. [Clinical study of viloxazine (author's transl)].
    Brunner H; Huck F
    Encephale; 1980; 6(3):247-57. PubMed ID: 7449724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of depression with viloxazine (Vivalan ICI). Behavior of ECG and other circulatory parameters].
    Ulbrich E; Hamouz W
    ZFA (Stuttgart); 1982 Jul; 58(20):1114-8. PubMed ID: 7148112
    [No Abstract]   [Full Text] [Related]  

  • 43. A double blind comparison of viloxazine and amitryptyline in involutional and endogenous depression.
    Botter PA
    Acta Psychiatr Belg; 1979; 79(2):198-209. PubMed ID: 532690
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Viloxazine in the treatment of depressive neurosis: a controlled clinical study with doxepin and placebo.
    McEvoy JP; Sheridan WF; Stewart WR; Ban TA; Wilson WH; Guy W; Schaffer JD
    Br J Psychiatry; 1980 Nov; 137():440-3. PubMed ID: 7008890
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Results of the clinical trial with viloxazine (Vivalan ICI). A part of the multicentre study (author's transl)].
    Kabes J; Dostal T
    Cesk Psychiatr; 1979 Aug; 75(4):225-31. PubMed ID: 393416
    [No Abstract]   [Full Text] [Related]  

  • 46. [Therapeutic use of viloxazine (Vivalan ICI) in depressed hospital out-patients (author's transl)].
    Kabes J; Dostal T
    Cesk Psychiatr; 1976 Dec; 72(6):384-9. PubMed ID: 1000703
    [No Abstract]   [Full Text] [Related]  

  • 47. Viloxazine in depressed women: clinical response and cardiovascular effects.
    Corona GL; Frattini P; Cucchi ML; Santagostino G; Schinelli S; Zerbi F; Cairoli S; Tosca P; Savoldi F
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):322-7. PubMed ID: 3623737
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Treatment of schizophrenia without symptoms with viloxazine].
    Kornhuber HH; Lisson G; Rissotto R
    Dtsch Med Wochenschr; 1985 Apr; 110(17):698. PubMed ID: 3886343
    [No Abstract]   [Full Text] [Related]  

  • 49. Do have antidepressants of the second generation anxiolytic properties?
    Kabes J; Dostal T; Balon R
    Agressologie; 1981 Nov; 22(E):11-3. PubMed ID: 7332041
    [No Abstract]   [Full Text] [Related]  

  • 50. Alcoholism and depression: a placebo controlled study with viloxazine.
    Altamura AC; Mauri MC; Girardi T; Panetta B
    Int J Clin Pharmacol Res; 1990; 10(5):293-8. PubMed ID: 2079386
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Synopsis of psychopathological, electroencephalographical, and pharmacokinetic variables during antidepressive treatment with viloxazine (author's transl)].
    Busch H; Bente D; Müller-Oerlinghausen B; Renfordt E
    Arzneimittelforschung; 1978; 28(8):1288-90. PubMed ID: 380579
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Age, therapeutic "milieu" and clinical outcome in depressive patients treated with viloxazine: a study with plasma levels.
    Altamura AC; Mauri MC; Guercetti G
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(1):67-75. PubMed ID: 3704174
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amoxapine and viloxazine: review of the literature with special reference to clinical studies.
    Ban TA
    Psychopharmacol Bull; 1979 Jul; 15(3):22-5. PubMed ID: 386404
    [No Abstract]   [Full Text] [Related]  

  • 54. [Viloxazine in the treatment of depression in the aged. Double-blind placebo study].
    De Leo D; Ceola A; Magni G; Renesto V; Pacchioni A
    Minerva Psichiatr; 1984; 25(2):127-30. PubMed ID: 6387360
    [No Abstract]   [Full Text] [Related]  

  • 55. [Nonpsychotic involutional inhibited depressions and psycho-organic deteriorations: treatment with Viloxazine and piracetam].
    Borromei A; Caramelli R; Conti M; Giancola LC; Guerra L
    Minerva Med; 1989 May; 80(5):475-82. PubMed ID: 2747975
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment of depressive conditions with viloxazine by the general practitioner].
    Haehn KD
    Fortschr Med; 1985 Apr; 103(15):408-12. PubMed ID: 3997018
    [No Abstract]   [Full Text] [Related]  

  • 57. Unwanted symptoms in depressed patients treated with viloxazine: an algorithm for identification of illness-related symptoms.
    Maistrello I; Grassi G; Bertolino A; Valerio P; Pistollato G; Soverini S
    Eur J Clin Pharmacol; 1983; 24(2):277-81. PubMed ID: 6840180
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparative trial of imipramine and phenobarbital in depressed patients seen in general practice.
    Wheatley D
    J Nerv Ment Dis; 1969 May; 148(5):542-9. PubMed ID: 4889754
    [No Abstract]   [Full Text] [Related]  

  • 59. A controlled study of nortriptyline and imipramine.
    Kessell A; Pearce TA; Holt NF
    Am J Psychiatry; 1970 Jan; 126(7):938-45. PubMed ID: 4902271
    [No Abstract]   [Full Text] [Related]  

  • 60. Modifications of libido and sex drive during treatment of minor depression with viloxazine.
    De Leo D; Magni G; Pavan L
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):176-7. PubMed ID: 6862720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.